Clinical Trial Update: A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating treatments to improve outcomes for adults with acute myeloid leukemia and high-risk myelodysplastic syndrome undergoing al…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• High-risk Myelodysplastic Syndrome

Snippet

Sponsor: University of Birmingham | Conditions: Acute Myeloid Leukaemia, High-risk Myelodysplastic Syndrome | Phase 2, Phase 3 | Status: UNKNOWN